Mortenson tops out Oregon pharmaceutical manufacturing facility
A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
